Being a provider of medical devices for health care professionals – many of which are critically needed to combat the evolving COVID-19 situation –...

Mölnlycke takes pride in having a highly trained workforce as many of our employees have a clinical background. 

Mölnlycke Health Care, a world leading MedTech company, has expanded its commitment to operations in the Middle East by extending its stake from 33.3% t...

Mölnlycke Health Care is pleased to announce our partnership with Phoenix Society for Burn Survivors.

Mölnlycke Health Care signed an agreement to acquire P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound...

Today we are delighted to announce the launch of the Mölnlycke integrated Annual Report 2023. Our dedication to revolutionising care for people and plan...

The Science Based Targets initiative (SBTi) has validated that the greenhouse gas (GHG) emission reduction targets submitted by Mölnlycke Health Care...

A decade ago, the antimicrobial foam exudate transfer dressing Mepilex® Transfer Ag was introduced as a new option for HCPs and patients in wound...